MYC proto-oncogene is located on chromosome 8q24 and encodes a transcription factor that regulates cell growth. It is mainly activated by amplification and chromosome translocation rearrangement, and its downstream target genes affect cell proliferation, DNA and protein synthesis and metabolism. In recent years, MYC gene abnormalities have become an important indicator of poor prognosis in patients with DLBCL.